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Background:MajorDepressiveDisorder (MDD)andanxietydisorders often co-occur,withpoorer
treatment response and long-term outcomes. However, little is known about the shared and dis-
tinct neural mechanisms of comorbid MDD and anxiety (MDD+Anx). This study examined how
MDD andMDD+Anx differentially impact cognitive control.
Methods: EighteenMDD, 29MDD+Anx, and 54 healthy controls (HC) completed the Parametric
Go/No-Go (PGNG) during fMRI, including Target, Commission, and Rejection trials.
Results:MDD+Anx hadmore activation in the anterior dorsolateral prefrontal cortex, hippocam-
pus, and caudate during Rejections, and inferior parietal lobule during correct Targets than MDD
and HC. During Rejections HC had greater activation in a number of cognitive control regions
compared to MDD; in the posterior cingulate compared to MDD+Anx; and in the fusiform gyrus
compared to all MDD. During Commissions HC had greater activation in the right inferior frontal
gyrus than all MDD. MDD had more activation in the mid-cingulate, inferior parietal lobule, and
superior temporal gyrus thanMDD+Anx during Commissions.
Conclusions: Despite similar performance, MDD and MDD+Anx showed distinct differences in
neural mechanisms of cognitive control in relation to each other, as well as some shared differ-
ences in relation to HC. The results were consistent with our hypothesis of hypervigilance in
MDD+Anx within the cognitive control network, but inconsistent with our hypothesis that there
would be greater engagement of salience and emotion network regions. Comorbidity of depres-
sion and anxietymay cause increased heterogeneity in study samples, requiring further specificity
in detection andmeasurement of intermediate phenotypes and treatment Targets.
K EYWORDS
anxiety, cognitive control, fMRI, inferior parietal lobule, Major Depressive Disorder
ABBREVIATIONS: ANOVA, analysis of variance; BOLD, blood-oxygen level dependent; CCN,
cognitive control network; GAD, Generalized Anxiety Disorder; HC, healthy controls; HDRS,
Hamilton Depression Rating Scale; MANOVA, multivariate analysis of variance;MDD,Major
Depressive Disorder;MDD+Anx,MDD and anxiety; NOS, not otherwise specified; PCA, principle
components analyses; PGNG, Parametric Go/No-go; RDoC, research domain criteria
1 INTRODUCTION
Major Depressive Disorder (MDD) is a lifetime disorder for many,
characterized by an insidious onset and a recurrent course. There is
evidence of substantial disability and burden with the disease,
including increased mortality due to suicide and morbidity due to
numerous other conditions for which MDD increases risk (e.g., hyper-
tension, obesity, diabetes (Greenberg et al., 2003; Kessler et al., 2006;
Musselman, Betan, Larsen, & Phillips, 2003; Nemeroff & Goldschmidt-
Clermont, 2012)). Currently, this detrimental course persists even in
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the context of early diagnosis, effective and efficient treatments, and
wellness maintenance (Blazer, Kessler, McGonagle, & Swartz, 1994;
Yanagita et al., 2006). Personalizedmedicine, or thematching of subdi-
agnostic specificity with Targeted treatments, is a broad goal for many
disorders including MDD and might result in more efficient, effective,
and lasting treatments. One strategy to achieve this goal is to better
identify meaningful subtypes of MDD, as it is a highly heterogeneous
disorder (Agosti & Stewart, 2001; Cassano, Musetti, & Perugi, 1992;
Joffe, Bagby, & Levitt, 1993; Schatzberg et al., 2000; Sullivan, Prescott,
& Kendler, 2002;Winokur, 1982).
Within this framework, there is growing evidence that presence of
a comorbid, often preexisting, anxiety disorder can change the pre-
sentation and prognosis of MDD for our standard treatments. Histor-
ically, comorbid MDD and anxiety results in poorer response to stan-
dard treatments (e.g., STAR-D (Fava et al., 2006, 2008) and greater
disruption in dexamethasone and metyrapone challenge of HPA axis
functioning (Lopez et al., 1999; Young, Abelson, &Cameron, 2004). Yet,
even in the era of subdiagnostic and pandiagnostic phenotyping, cham-
pioned within the Research Domain Criteria (RDoC) initiative of the
NIMH, studies of comorbid anxiety as a meaningful subtype of MDD
are quite limited. Furthermore, the nuances in methods design, sam-
pling characteristics, and theoretical underpinnings make it difficult to
integrate these studies. Task-based fMRI studies with emotional stim-
uli (Beesdo, Lau, et al., 2009; Hamilton et al., 2015) report differential
effects for emotional stimuli based upon diagnosis and valence.
Another study showedMDD-specific midcingulate gyrus hyperactiva-
tion, interpreted as hyperviglance, in response to reward anticipation
that was not present in MDDwith Panic Disorder (Gorka et al., 2014).
Two symptom-based neuroimaging studies evaluated depression and
anxiety symptoms in relation to connectivity patterns (Oathes, Pate-
naude, Schatzberg, & Etkin, 2015; Spielberg et al., 2014) and demon-
strated some differential patterns in salience/emotion networks and
cognitive control networks. These baseline resting state connectivity
networks offer an intriguing way to understand network synchroniza-
tionandharmonics absent anexperimental paradigm, andarepowerful
windows into how regions within a given network may work together
to a greater or lesser extent (Yeo et al., 2011). Recent work is now link-
ing these network patterns to features of illness and disease course
(Jacobs et al., 2014, 2016). Overall, these initial reports suggest that
differential responsiveness to emotional valence, reward, and cogni-
tive challenge, as well as resting state connectivity patterns may be
present based upon the presence or absence of anxiety disorder in
the context of MDD. It is unclear whether many studies demonstrat-
ing increased activation in regions within and outside of the salience
and emotional network are reflective of hypervigilance to threatening
stimuli, increased depth of processing of emotionally congruent stim-
uli, or of increased attempts at regulation of emotional content.
To this end, one intriguing line of research includes directed manip-
ulation of the extent of regulation of emotional content, in an explicit
paradigm where study participants are directed to look passively,
maintain an initial emotional response, or reappraise emotional stim-
uli to diminish both salience and depth of processing of these stim-
uli (Ochsner et al., 2004). This paradigm has led to some interesting
between-group differences in regions thought to be a part of the cog-
nitive control network (Burklund, Craske, Taylor, & Lieberman, 2015).
However, manipulation checks within this design rely on both partici-
pant awareness of emotional responses, and participant ability to rate
their own effectiveness in regulation. Therefore, it is unclear whether
increased engagement of cognitive control regions in HC relative to
MDD and/or anxiety patients relates to greater awareness, effort, or
success in regulation (Langenecker et al., 2007). Furthermore, cur-
rent data do not clarify the duration of emotional responses at an
individual or group level, potentially leading to confounding of con-
trol conditions within the patient groups that could lead to dimin-
ished contrast differences between explicit reappraisal and look only
conditions.
One way to provide convergent evidence about the nature of
weakened or diminished emotion regulation in MDD and MDD
plus anxiety would be to attempt to link emotion regulation find-
ings with cognitive control results. To our knowledge, however, few
studies have investigated explicit cognitive control in these pop-
ulation without potentially confounding emotional stimuli (Mitter-
schiffthaler et al., 2008, Siegle et al., 2007; Videbech et al., 2004;
Wagner et al., 2006). Furthermore, to our knowledge no studies com-
paring MDD alone with MDD plus anxiety have specifically examined
cognitive control, a regulatory mechanism for thoughts and emotions
supportedby lateral andmedial prefrontal and inferior parietal regions
that make up the cognitive control network. Importantly, performance
and neuroimagingmeasures have demonstrated that disruption of this
network may contribute to mood dysregulation in MDD (see (Lange-
necker, Jacobs, & Passarotti, 2014), but it is not clear if this is the case
for MDD comorbid with anxiety). Given the limited research exam-
ining differences between MDD and MDD comorbid with anxiety, it
is crucial that we better understand the similarities and differences
in MDD and MDD comorbid with anxiety to help inform diagnostic
overlaps/clarity and potentially differential treatment strategies. It is
possible that these groups differ according to valence, context, and
cognitive control capacity, consistent with the underlying theories and
symptoms related to each diagnosis. It is also possible that results from
emotion challenge task andemotion regulationparadigms couldbedis-
ambiguated through the use of cognitive control tasks without emo-
tional stimuli or explicit emotional conditions.
As such, we have proposed and pursued a line of research in cog-
nitive control, with the expectation that individuals with MDD comor-
bidwith anxiety have normative cognitive control capacity (regulation)
and heightened emotion response (negative appraisal), while individ-
uals with MDD alone have diminished cognitive control (regulation)
and blunted (positive appraisal) emotion response (see Fig. 1) (Lange-
necker et al., 2005, 2014), although only a subset of the hypotheses
put forth within this model are tested here.We hypothesize thatMDD
comorbid with anxiety should demonstrate aspects of hypervigilance
and increased activation during cognitive control, whereasMDDalone
may demonstrate hypoactivation and decreased regulatory skills dur-
ing a cognitive control task without any emotional context. It is impor-
tant to note that in the current study we used the DSM-IV definition
ofMDDwith comorbid anxiety, we did not use theDSM-5 definition of
MDDwith anxious distress, as this change in definition occurred after
the participant data were collected.
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F IGURE 1 Illustrates our hypothesis that individuals with MDD comorbid with anxiety have normative cognitive control capacity (regulation)
and heightened emotion response (negative appraisal), while individuals with MDD alone have diminished cognitive control (regulation) and
blunted (positive appraisal) emotion response.






n= 29 Group Comparisons
Age 33.80 (11.56) 34.28 (11.69) 33.24 (11.25) ns
Sex (M/F) 16/38 7/11 8/21 ns
Education 15.60 (1.90) 15.33 (1.97) 14.82 (2.09) ns
Shipley IQ 105.93 (16.67)a 105.14 (13.78)b 105.88 (11.24)c ns
HDRS∗ 0.85 (1.90) 20.76 (7.25) 20.71 (6.08) HC<MDD,MDD+Anxiety
NEO-PI neuroticism∗ 42.27 (8.82)a 63.17 (13.09)b 65.94 (12.75)c HC<MDD,MDD+Anxiety
NEO-PI extraversion∗ 50.33 (9.28)a 37.33 (9.22)b 34.89 (11.74)c HC<MDD,MDD+Anxiety
PGNG performance
Go-accuracy 0.89 (0.13) 0.85 (0.16) 0.87 (0.14) ns
No-go accuracy 0.67 (0.16) 0.70 (0.19) 0.69 (0.18) ns
Response time to go Targets* 482.61 (41.43) 524.42 (40.48) 507.46 (56.27) HC<MDD,MDD+Anxiety
Values aremeans and standard deviations unless otherwise noted;





2 MATERIALS AND METHODS
2.1 Participants
Twenty-one participants with diagnosis of MDD, 32 participants with
a comorbid MDD and anxiety disorder diagnosis (MDD+Anxiety), and
56healthy controls (HC) completed the studybetween2003and2012.
Clinical assessment was conducted using the structured clinical inter-
view for DSM-IV (First, Spitzer, Gibbon, & Williams, 1996). Prior to
enrollment in the study, participants were unmedicated and, in order
to eliminate medication and hormonal effects on functional neural
activation, had been medication-free from SSRIs or SNRIs for at least
90 days and from all other medications (including birth control) for
at least 30 days. All participants were right handed. Individuals who
smokedcigarettes,met criteria for alcohol abuseorother drug abuse in
thepast 2 years, or reporteduseof illegal drugs in thepast 2 yearswere
excluded. In addition, HCs could not meet current or past criteria for
MDD ormost other Axis I or II psychiatric disorders, excluding remote
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TABLE 2 Task effect
Contrast/lobe BA x y z Z k
Targets −
Frontal
Middle 9/46 46 38 20 6.51 1,094
9/46 −38 38 28 7.62 902
Precentral/postcentral/inf. parietal 6/4/3/7/40 −32 −26 48 Inf 16,312
Midcingulate/suppl. motor 32/24/6 −4 2 52 Inf ^
Parietal
Postcentral 40/7 60 −16 18 4.48 57
Inferior parietal 39/40/7 48 −40 42 7.68 1,921
Occipital
Lingual 18 26 −92 −4 7.53 96
Lingual/inferior 17/18/19 −26 −92 −2 7.25 607
Middle 19/37 46 −74 −10 Inf 174
Subcortical
Cerebellum (Uncus/culmen/declive) 6 −56 −16 Inf 1,233
Commissions
Frontal
Anterior cingulate/dorsomedial 32/24 8 30 28 7.62 6,606
Inferior, middle, insula 13/47 −34 16 6 Inf 3,332
13/47 32 22 4 7.21 1,484
Temporal
Superior 38 52 14 −10 4.8 73
Middle 21 54 −32 −4 3.07 77
Parietal
Supramarginal 40 58 −48 28 6.85 1,705
40 −58 −46 28 6.89 1,854
Subcortical
Thalamus 4 −22 0 3.99 119
Caudate −12 2 10 3.87 90
Cerebellum (uncus) 16 −54 −26 3.75 172
Rejections
Frontal
Inferior/middle/insula 13/47/46/9 −32 14 6 7.13 14,237
13/47/46/9 48 32 28 6.68 ∧
Cingulate/superior 6/24/32 12 2 64 6.91 ∧
Temporal
Middle 21 −58 −28 −6 3.36 67
21 60 −34 −6 4.27 153
Parietal
Postcentral 43 −64 −16 18 3.96 86
40/7 −30 −66 44 5.56 2,395
39/40 60 −46 32 6.44 2,593
Occipital
Middle 19 −42 −70 −2 5.36 521
19 48 −74 −6 5.01 172
∧Part of larger bilateral cluster for k.
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history of substance use disorders (see exclusion criteria above). HCs
had no first-degree relatives with a history of psychiatric illness. Par-
ticipants underwent fMRI and completed several measures including
the Hamilton Depression Rating Scale (HDRS (Hamilton, 2004) and
the Neuroticism and Extraversion Scales from the NEO-PI (Costa &
McCrae, 1992).
A number of different movement parameters were evaluated to
determine if, and for which individuals, blood-oxygen level dependent
(BOLD) signal estimates were compromised (Jacobs et al., 2014; Jo
et al., 2013; Power et al., 2012). We settled on using an outlier devi-
ation statistic, in which realignment values from MCFLIRT were used
to estimate a standard deviation of the realignment required in pitch,
roll and yaw, subsequently averaged across all six runs. As a result, 5
individuals were excluded for movement and an additional two were
removed due to substantial signal distortion, resulting in a final sample
of 18MDD, 29MDD+Anx, and 54HC. Informed consentwas obtained
according to the guidelines of the Institutional Review Boards of The
University of Michigan (UM) and consistent with the Declaration of
Helsinki. Participants were compensated for their participation.
2.2 Cognitive control measure
2.2.1 Parametric Go/No-Go task (PGNG)
The PGNG is a 24-min task completed during fMRI, which measures
attention (Targets) and set-shifting, processing speed, and correct
responses (Rejections) and incorrect responses (Commissions) to lure
trials as a part of cognitive control (Langenecker et al., 2005; Lange-
necker et al., 2007; Votruba & Langenecker, 2013). Participants were
asked to respond with their right index finger using a button box as
quickly as possible to a string of particular Target letters for the “go”
condition. In the “no-go” condition, they may only respond to one of
these Target letters in an alternating or nonrepeating order. Scores
were computed for the average correct Targets for “go” items across
all three levels of difficulty in the task, average correct Rejections of
“no-go” items across the two more difficult levels of the task, and “go
response time” across all three levels of the task. Formore information
see (Votruba & Langenecker, 2013).
2.3 Data acquisition
Whole brain imaging was performed with a 3.0 T GE Signa scan-
ner (Milwaukee, WI) using a standard radio frequency coil and T2*-
weighted pulse sequence. BOLD functional images were collected
using a gradient-echo axial forward–reverse spiral sequence (Glover
& Thomason, 2004) at UM between 2003 and 2012. The following
parameters were used: repetition time = 2,000 m, echo time = 30
ms, flip angle = 90%, field of view = 22 cm, 64 by 64 matrix, slice
thickness = 4 mm, 29 slices. An axial T1 SPGR structural image was
obtained for each using 108–124 axial images between 1 and 1.5 mm
in thickness for spatial normalization. During scanning, participants
completed the PGNG task using a button box and the importance of
remainingmotionlesswas conveyed toeachparticipant. Therewere six
runs of the PGNG, each lasting 4 min and 20 s, and acquiring 120 vol-
umes. The same scanner and acquisition sequencewas used for all par-
ticipants and therewas no relationship between the year the fMRIwas
performed and extracted activation of the BOLD signal (all p-values >
.05).
2.4 MRI processing
Preprocessingof fMRIdatawas conductedusing SPM8 (http://www.fil.
ion.ucl.ac.uk/spm/) and AFNI (http://afni.nimh.nih.gov/afni/). Data
were despiked using AFNI. All data were then slice-time corrected in
SPM8 and realigned in FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) using
MCFLIRT (Jenkinson, Bannister, Brady, & Smith, 2002). Anatomical
and functional images were coregistered and normalized to Montreal
Neurological Institute (MNI) space using SPM8. Smoothing was
completed with a full width at half maximum filter of 5 mm. First level
models were built in SPM8 using roll, pitch, and yaw realignment
movement regressors from FSL for each run. The subtraction method
was used to create contrast images and second level models were built
in SPM8.
2.5 Statistical procedures
Analyses for demographic and clinical characteristics were carried out
using SPSS 20.0 (IBM). Group differences in demographic and clinical
characteristics were assessed using analysis of variance (ANOVA) or
chi-square, as appropriate. Group differences in PGNG performance
was examined using one multivariate analysis of variance (MANOVA)
model. Results were deemed statistically significant when p-values <
.05.
fMRI data were evaluated with 3 (MDD+Anx/MDD/HC) × 1
ANCOVAs with Targets, Commissions, and Rejections as separate
dependent variables andwith gender, age, and task performance accu-
racy as covariates in each of the three models. Main effects were
followed up using t-tests. Significance thresholds were derived with
AlphaSim24 (P< .005, k> 55).
3 RESULTS
3.1 Demographic and clinical characteristics
Participant characteristics are reported in Table 1. As expected, MDD
andMDD+Anxietyhad significantly higherHDRS,NEO-PI neuroticism
scores, and NEO-PI extraversion scores relative to HC, but no other
group differences were found.
3.2 PGNG performance
Groups did not differ on “go accuracy” (percent correct Targets) or on
“no-go accuracy” (percent correct inhibition; see Table 1). On the other
hand, bothMDDgroups had significantly longer response times for “go
Targets” (correct Targets; see Table 1).
972 CRANE ET AL.
F IGURE 2 Group differences in cognitive control neural activation during Targets (A), Rejections (B), and Commissions (C, D). The extent and
relative group differences in activation are shown in each bar graph. Panel A shows task activation during Targets (green), as well as regions where
HC had more activation than MDD only (orange) and regions where MDD+Anx had more activation than MDD and HC (yellow). The extracted
ROI data for each group from the yellow cluster is plotted below. Panel B shows task activation during Rejections (yellow) and also a region in the
anterior prefrontal cortex where MDD+Anx had more activation than MDD (purple). The extracted ROI data for each group from the anterior
prefrontal cortex purple cluster is plotted below. Panel C shows task activation during Commissions (red) and regions in the prefrontal cortex
where MDD only had more activation than MDD+Anx (blue). The extracted ROI data for each group from the peak blue cluster is plotted below.
Panel D shows task activation duringCommissions (red) and a region in the right inferior frontal gyruswhereHChadmore activation than allMDD
(green). The extracted ROI data for each group from the green cluster is plotted below.
TABLE 3 Group differences for Targets
Contrast/lobe BA x y z Z k
HC is greater thanMDDonly
Temporal
Superior 22/40/39 −56 −42 14 3.54 120
HC is less thanMDDplus anxiety
Parietal
Inferior 40 56 −40 44 3.86 111
MDDonly is less thanMDDplus anxiety
Frontal
Anterior cingulate 32/24 12 32 20 3.64 75
Parietal
Inferior 39/40 50 −42 44 3.86 1,112
Temporal
Superior 22/39 −58 −42 12 4.84 173
3.3 PGNG task neural activation
Neural activation during Targets, Commissions, and Rejections are
reported in Table 2. In general, Targets and Rejections largely acti-
vated the cognitive control network (CCN), while Commissions acti-
vated paralimbic regions and parietal regions thought to be involved in
visual-haptic integration and error processing (see Table 2 and Fig. 2).
Figure 2 includes illustration of post hoc differences for key regions
within theCCN that differed between the three groups to highlight the
degree and direction of differences.
3.4 Group differences in cognitive control neural
activation
3.4.1 Targets
HC had more activation during Targets than MDD in superior tempo-
ral regions (see Table 3). However, HC had less activation during Tar-
gets thanMDD+Anxiety in inferior parietal areas within the CCN (see
Table 3 and Fig. 2, panel A). MDD+Anxiety had greater activation dur-
ing Targets thanMDD in limbic and parietal regions within the CCN, as
well as superior temporal regions (see Table 3 and Fig. 2, panel A).
3.4.2 Rejections
HC had more activation during Rejections than MDD throughout the
brain in frontal, parietal, occipital, temporal, and subcortical regions;
HC had more activation during Rejections than MDD+Anxiety in the
posterior cingulate; and HC had more activation during Rejections
than all MDD in the fusiform gyrus (see Table 4). MDD+Anxiety had
more activation during Rejections than MDD in regions outside of the
CCN: the anterior prefrontal cortex, hippocampus, and caudate (see
Table 4 and Fig. 2, panel B).
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TABLE 4 Group differences for Rejections
Contrast/lobe BA x y z Z k
HC is greater thanMDDonly
Frontal
Superior 10 28 54 20 2.99 64
Middle 9 28 30 34 3.07 105
Parietal
Posterior Cingulate 31 8 −36 42 3.02 66
Occipital
Cuneus 17/18 22 −90 14 3.65 149
Temporal
Fusiform 37 −36 −42 −8 3.9 148
Subcortical
Caudate −18 22 8 4.03 94
HC is greater thanMDDplus anxiety
Parietal
Posterior Cingulate 31 10 −18 44 3.21 60
MDD is less thanMDDplus anxiety
Frontal
Superior 6 20 28 50 3.59 286
Temporal
Hippocampus 34 −40 4 4.2 193
Subcortical
Caudate −12 28 0 4.23 75
HC is greater than all MDD
Temporal
Fusiform gyrus 37 −36 −42 −10 3.47 64
TABLE 5 Group differences for Commissions
Contrast/lobe BA x y z Z k
MDDonly is greater thanMDDplus anxiety
Frontal
Precentral 4 −36 −8 60 3.46 60
Midcingulate/suppl. motor 32/6 −8 10 56 3.2 74
Parietal
Inferior 40 −60 −32 28 3.26 59
Temporal
Superior 22 −58 −56 16 3.75 93
HC is greater than all MDD
Frontal
Inferior 10 42 50 0 3.14 77
3.4.3 Commissions
MDD had more activation during Commissions than MDD+Anxiety
within regions proposed for error processing during a visual, language-
based task including the midcingulate, inferior parietal lobule, and
superior temporal gyrus, as well as within regions involved in motoric
response including the precentral gyrus and supplemental motor cor-
tex (see Table 5 and Fig. 2, panel C). HC had more activation during
Commissions than all MDD outside of the network activated by the
task, in the right inferior frontal gyrus (see Table 5 and Fig. 2, panel D).
3.5 Relationships with trait neuroticism
and extraversion
In regions that differed between MDD andMDD+Anxiety, we further
evaluated whether these differences were present independent of
or in concert with trait neuroticism and extraversion. It is possible
that trait neuroticism and extraversion would provide a larger effect
sizes in these regions, capturing individual differences in anxiety
symptoms across the lifetime as opposed to episodic experiences that
could be current or remote. This can be exacerbated by known poor
recall for degree, duration, and extent of past symptoms, especially
during childhood (Beesdo, Knappe, & Pine, 2009). To test this dimen-
sional hypothesis, we extracted activation and correlated activation
with trait neuroticisim and extraversion in the MDD groups, alone
and together. Neuroticism and extraversion were not significantly
related to activation in regions that differed between MDD and
MDD+Anxiety (all p-values> .05).
3.6 Exploratory analysis of anxiety subtypes
We grouped individuals with MDD and a comorbid anxiety disor-
der into one group due to the fact that many participants in the
MDD+Anxiety group had more than one anxiety disorder diagnosis
(n = 12), while only small subsets had a single diagnosis including
Social Phobia (n = 5), Generalized Anxiety Disorder (GAD; n = 4), Anx-
iety Disorder Not Otherwise Specified (NOS; n = 4), Panic Disorder
(n = 2), and Simple Phobia (n = 2). However, we wanted to examine
whether MDD+Anxiety participants with different anxiety disorders
differed in their patterns of activation in regions that MDD+Anxiety
had greater activation thanMDD. For data reduction purposes, we ran
principle components analyses (PCA) with extracted activation during
Targets from three regions in which MDD+Anxiety had greater acti-
vation than MDD (see Table 3) and the three variables loaded onto
one factor (81.25%variance explained, eigenvalue= 2.44).We also ran
PCA with extracted activation during Rejections from four regions in
which MDD+Anxiety had greater activation than MDD (see Table 4)
and the four variables loaded onto one factor as well (59.30% vari-
ance explained, eigenvalue = 2.37). Due to the very small sample sizes
of the Panic Disorder and Simple Phobia groups, we combined these
groups together to create a single group who has one anxiety disor-
der. ANOVAs with anxiety subtype as the independent variable and
the Target activation factor score andRejection activation factor score
as separate dependent variables with MDD and MDD+Anxiety par-
ticipants found there was a significant difference between groups for
the Target activation factor score (F(5,47) = 7.02, p < .001) and for the
Rejection activation factor score (F(5,47) = 5.96, p < .001). Post hoc
analyses using Tukey’s HSD indicated that MDD alone had lower Tar-
get activation factor scores (M = −0.58, SD = 0.59) than MDD with
more than one more than one anxiety disorder diagnosis (M = 0.16,
SD = 0.48), MDD with Social Phobia (M = 0.51, SD = 0.33), MDD with
anxiety disorder NOS (M = 0.38, SD = 0.25), and MDD with one anx-
iety disorder (Panic Disorder or Simple Phobia; M = 0.49, SD = 0.25),
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F IGURE 3 Exploratory analyses of group differences among MDD and MDD+Anxiety subtypes in cognitive control neural activation during
Targets and Rejections. The extent and relative group differences in factor scores of activation are shown in each bar graph. TheMDD alone group
is shown as “none” (n = 18), while MDD+Anxiety subtypes are shown as “>1 Anx Dx” (more than one anxiety disorder diagnosis; n = 12), “Social
Phobia” (n = 5), “GAD” (Generalized Anxiety Disorder; n = 4), “Anx Dx NOS” (Anxiety Disorder Not Otherwise Specified; n = 4), and “other, 1 Anx
Dx” (Panic Disorder (n= 2) and Simple Phobia (n= 2)).
but there was no difference in Target activation factor scores between
MDD alone andMDDwith GAD (although trending (p= .07);M= 0.21,
SD = 0.25). MDD+Anxiety subgroups did not differ from one another
and there were no other group differences in Target activation fac-
tor scores. Additionally, post hoc analyses using Tukey’s HSD revealed
MDD alone had lower Rejection activation factor scores (M = −0.84,
SD = 0.90) than MDD with more than one more than one anxiety dis-
order diagnosis (M = 0.27, SD = 0.62), MDD with Social Phobia (M =
0.42, SD = 0.70), MDD with GAD (M = 0.39, SD = 0.17), and MDD
with anxiety disorder NOS (M = 0.61, SD = 0.58), but MDD alone did
not differ fromMDDwith one anxiety disorder (PanicDisorder or Sim-
ple Phobia;M = 0.05, SD = 0.49) in Rejection activation factor scores.
MDD+Anxiety subgroups did not differ from one another and there
were no other group differences in Rejection activation factor scores.
MDD and MDD+Anxiety subtype activation factor scores for Targets
and Rejections are shown in Figure 3.
4 DISCUSSION
The present report highlights one potential way to reduce heterogene-
ity in the study of MDD, by investigating MDD alone in relation to
MDD with comorbid anxiety. We found group differences between
all MDD participants and the HC group, as might be expected based
upon prior work, including decreased activation within right inferior
frontal gyrus when participants were unable to demonstrate cogni-
tive control (Commission errors) (Hampshire et al., 2010). Notably,
and consistent with other biological markers and reports, the pres-
ence of comorbid anxiety, even in the context of equal depression
symptoms, resulted in differential activationpatterns for attention and
cognitive control processes, as measured by Targets, correct Rejec-
tions, andCommission errors. Typically, thepatternwasof greater acti-
vation in comorbidMDD and anxiety relative toMDD alone.
There are a number of important results of the present study. First,
it is an event-related design, based upon performance. As such, there
can be separation of subgroup by behavior activation differences,
with activation differences observedwithin the correct Target, correct
Rejection, and incorrect Commission analyses. First, this allows us to
separate out elements of the CCN that are engaged for correct, suc-
cessful regulation compared to those that are engaged within the con-
text of failure (Langenecker et al., 2007). Errors result in more exten-
sive engagement of midline cingulate and anterior insula (sometimes
referred to as salience network (Sridharan, Levitin, & Menon, 2008)),
whereas successful regulation results in more extensive engagement
of ventrolateral and dorsolateral prefrontal cortex (often referred to
as CCN proper). Within this framework, greater confidence might be
ascribed to ventro and dorsolateral prefrontal engagement for emo-
tion regulation paradigms as being reflective of successful regulation,
and salience network as reflective of failure to do so effectively and
efficiently.
Moreover, for dissociating MDD and MDD plus anxiety, there are
nuances in results that are aided by the ability to separate out differ-
ent event types. In one case, this results in greater activation within
the CCN during Targets in the comorbid group, consistent with our
hypothesis of diminished cognitive control engagement in the MDD
alone group. The results were also consistent with our hypothesis of
hypervigilance during Targets within the comorbid group, with more
activation in the inferior parietal lobule relative to both other groups
(Nitschke, Heller, Palmieri, & Miller, 1999; Gold, Morey, & McCarthy,
2015). There was not, however, any evidence of differential engage-
ment of typical salience and emotion network regions within the
comorbid group (e.g., amygdala, subgenual anterior cingulate, ante-
rior insula). Importantly, exploratory analyses of MDD+Anxiety sub-
types generally supported that these results were true across dif-
ferent anxiety disorders, supportive of the broader RDoC hypoth-
esis about some shared dimensions across disorders (Cuthbert,
2005).
CRANE ET AL. 975
In addition, and contrary to expectation, for Commission errors
the MDD alone group exhibited increased activation within regions
proposed for error processing (and also cognitive control) during
a visual, language-based task including the midcingulate (putatively
within salience network), inferior parietal lobule, and superior tempo-
ral gyrus. This increase in activation was in comparison to the comor-
bid group, emphasizing the potential value and specificity gained in
studying MDD alone separate from the comorbid condition. While
some of these regions are not within the salience and emotional net-
works, these results are contrary to the idea that reactivity to errors is
somehow exaggerated within the comorbid group, and is not related
to or consistent with trait anxiety levels as measured by neuroti-
cism (or inversely with extraversion) (Aarts & Pourtois, 2010). We
do note that the sample was unmedicated, allowing us to avoid com-
mon concerns about activation differences that might result from
treatment. Moreover, different treatments might be entertained and
engaged based upon the presence of a comorbid anxiety disorder,
so we were able to avoid potential treatment by subtype medication
effects.
There are also limitations that are important to review. First, while
the sample ofMDD subjects recruited for the studywas large (N= 55),
after dividing into subtypes and removing those with significantmove-
ment and distortion, the subgroup samples were more modest. The
MDD alone group was only 18 individuals. Second, there was a rela-
tively broad age range studied, from18 to 57, whichmightmask signif-
icant comorbidity based differences that are influenced by age. Third,
there were no performance differences between theMDD subgroups,
although both were slower in “go” response time relative to the HC
group. However, it is important to note that a key dimensional marker
of anxiety, trait neuroticism, was elevated in both MDD groups, and
only to a nominally greater extent in the comorbid MDD group. Fur-
thermore, other measures of negative and positive affect (e.g., PANAS,
BIS/BAS, MASQ) were not captured in the whole sample and there-
fore we were not able to more thoroughly examine how negative
and positive affect may contribute to some of the group differences
found (Spielberg et al., 2014).Moreover, althoughexploratory analyses
generally found that anxiety disorders included in the MDD+Anxiety
group had similar overall patterns of activation during Targets and
Rejections, each subtype of anxiety disorders examined had small sam-
ple sizes, limiting our ability to better understand how specific anxiety
disorders may differ from one another. It will be important for future
studies to examine potential differences in different anxiety disorders,
alone and in combination withMDD.
5 CONCLUSION
In summary, the presence of a comorbid anxiety disorder within the
context of MDD may obscure or accentuate differences in relation to
HC groups, based upon activation results reported herein. Addition-
ally, more refined subtyping strategies have been employed with self-
reported anxiety scales that further strengthen this line of inquiry. The
average earlier onset of anxiety disorders relative to MDD (Kendler
et al., 1995), as well as the shared factor structure for these disor-
ders (Vollebergh et al., 2001) in many self-report measures, may have
glossed over some nuanced differences between these groups. Cog-
nitive control, although relatively heavily emphasized within emotion
challenge and regulation paradigms, has been understudied in isola-
tion andmayprovide a context formore clearly distinguishing between
these groups and also in pursuing dimensions highlighted within the
RDoC initative (Mitterschiffthaler et al., 2008; Raynor, Jackson, &Wil-
son, 2016; Siegle et al., 2007; Videbech et al., 2004; Wagner et al.,
2006). Furthermore, cognitive control paradigms without emotional
stimuli/challenges can then be integrated with emotion challenge and
regulationparadigms in future studies tobetter disambiguate indepen-
dent and interactive components of cognitive systems and negative
valence systems.
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